Metraipolis › archive › dc_acca783485a7
NEDA-3 using cladribine for multiple sclerosis: effectiveness data from a Norwegian hospital — Europe PMC PMID:41561333
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41561333
- DOI
- 10.3389/fneur.2025.1698334
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:15:49.603Z
- SHA-256 of the archived text
3a83121bf67073ac113f369b6146bd4ea244484945bf76aec24f6932b487aba4- Stable URL of this page
https://metraipolis.com/documento/dc_acca783485a7
How to cite
NEDA-3 using cladribine for multiple sclerosis: effectiveness data from a Norwegian hospital — Europe PMC PMID:41561333 — Europe PMC (en), https://europepmc.org/article/MED/41561333 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_acca783485a7 (Metraipolis archive dc_acca783485a7, sha256 3a83121bf67073ac113f369b6146bd4ea244484945bf76aec24f6932b487aba4)
BibTeX
@misc{dcacca783485a7,
title = {NEDA-3 using cladribine for multiple sclerosis: effectiveness data from a Norwegian hospital — Europe PMC PMID:41561333},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41561333},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_acca783485a7; sha256 3a83121bf67073ac113f369b6146bd4ea244484945bf76aec24f6932b487aba4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41561333. Agents can read the archived copy with the MCP tool read_document.